Therapeutic uses of the hypervariable region of monoclonal antib

Details Therapeutic uses of the hypervariable region of monoclonal antib Therapeutic uses of the hypervariable region of monoclonal antib

1992-06-15

1999-12-28

Scheiner, Toni R.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

4241331, 4241521, 4241531, 4241551, 4241731, 4241781, 4241831, 5303873, 5303877, 5303882, 5303887, 5303886, 5303888, 5303896, 5303897, 5303913, 5303917, C07K 1628, C07K 1646, A61K 39395

Patent

active

060078146

ABSTRACT:
Therapeutic agents and methods for treating and diagnosing leukemia are provided. Such agents comprises monoclonal antibody M195, a polypeptide capable of binding to the antigen of M195, or a chimeric antibody such a peptide, conjugated to a cytotoxic agent, e.g. a radioisotope or alone. Methods for delivering genetic information to a targeted cell is also provided.

REFERENCES:
patent: 5225539 (1993-07-01), Winter

Affiliated with

Also associated with

Rating

Therapeutic uses of the hypervariable region of monoclonal antib does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic uses of the hypervariable region of monoclonal antib, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of the hypervariable region of monoclonal antib will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2380482